Latest Drug-eluting stent Stories
SINGAPORE, May 28, 2014 /PRNewswire/ -- Biosensors International Group, Ltd.
DUBLIN, May 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wkbfxj/coronary_stents)
-- Sustained Safety Profile -- DURHAM, N.C., May 23, 2014 /PRNewswire/ -- Micell Technologies, Inc.
COMBO(TM) Dual Therapy Stent shown to actively promote rapid endothelialization and deliver long-term, true vessel healing HONG KONG, May 23, 2014 /PRNewswire/ --
LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
EVOLVE Study Data Presented Today at EuroPCR 2014 Also Demonstrate Excellent Safety Profile NATICK, Mass., May 21, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reported
Company to Present at European Symposium Titled MGuard(TM) Embolic Protection Stent: The Importance of Thrombus Management in STEMI Primary PCI BOSTON, May 20, 2014 /PRNewswire/ --
-- Oral Presentations to Include New Long-Term Results from First-in-Human Study -- DURHAM, N.C., May 15, 2014 /PRNewswire/ -- Micell Technologies, Inc.
SINGAPORE, May 5, 2014 /PRNewswire/ -- Biosensors International Group, Ltd.
NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting
- an ornament or knob in the shape of a flower
More Images (2 images) »